Which Genetic Determinants Should be Considered for Tacrolimus Dose Optimization in Kidney Transplantation? A Combined Analysis of Genes Affecting the CYP3A Locus-Reference-Cited by-同舟云学术

Which Genetic Determinants Should be Considered for Tacrolimus Dose Optimization in Kidney Transplantation? A Combined Analysis of Genes Affecting the CYP3A Locus

Published:2015-06 Issue:3 Volume:37 Page:288-295
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Bruckmueller Henrike,Werk Anneke Nina,Renders Lutz,Feldkamp Thorsten,Tepel Martin,Borst Christoffer,Caliebe Amke,Kunzendorf Ulrich,Cascorbi Ingolf

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference29 articles.

1. . Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients.;Benkali;Clin Pharmacokinet,2009

2. . Tacrolimus-induced nephrotoxicity and genetic variability: a review.;Gijsen;Ann Transplant,2012

3. . Clinical pharmacokinetics of tacrolimus.;Venkataramanan;Clin Pharmacokinet,1995

4. . Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression.;Kuehl;Nat Genet,2001

5. . The genetic determinants of the CYP3A5 polymorphism.;Hustert;Pharmacogenetics,2001

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Composite CYP3A (CYP3A4 and CYP3A5) phenotypes and influence on tacrolimus dose adjusted concentrations in adult heart transplant recipients;The Pharmacogenomics Journal;2024-02-15

2. Effects of CYP3A4*22 and POR*28 variations on the pharmacokinetics of tacrolimus in renal transplant recipients: a meta-analysis of 18 observational studies;BMC Nephrology;2024-02-06

3. CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients;Frontiers in Pharmacology;2023-11-06

4. Composite CYP3A (CYP3A4 and CYP3A5) phenotypes and influences on tacrolimus dose adjusted concentration in adult heart transplant recipients;2023-05-16

5. Composite CYP3A phenotypes influence tacrolimus dose-adjusted concentration in lung transplant recipients;Pharmacogenetics and Genomics;2022-04-07